Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis

Anticancer Research

Volumn 34, Issue 9, 2014, Pages 4969-4975

  Kassayová, Monika ^a   Bobrov, Nikita ^b   Strojný, Ladislav ^b   Kisková, Terézia ^a   Mikeš, Jaromír ^a   Demečková, Vlasta ^a   Orendáš, Peter ^a   Bojková, Bianka ^a   Péč, Martin ^c   Kubatka, Peter ^c   Bomba, Alojz ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Med Faculty of Safarik University   (Slovakia)

^c University Teaching Hospital in Martin   (Slovakia)

Author keywords

7,12 dimethylbenz a anthracene; Breast cancer; Lactobacillus plantarum; Oligofructoseenriched inulin; Prebiotic; Probiotic

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; FRUCTOSE OLIGOSACCHARIDE; INTERLEUKIN 10; INULIN; OLIGOFRUCTOSE ENRICHED INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD SAMPLING; BREAST TUMOR; CANCER INCIDENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIETARY FIBER; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TUMOR VOLUME; 7,12-DIMETHYLBENZ[A]ANTHRACENE; ANIMAL; BIOSYNTHESIS; BREAST CANCER; CANCER STAGING; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DIET; DISEASE MODEL; IMMUNOLOGY; METABOLISM; OLIGOFRUCTOSE-ENRICHED INULIN; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TUMOR INVASION;

7,12-DIMETHYLBENZ[A]ANTHRACENE; BREAST CANCER; LACTOBACILLUS PLANTARUM; OLIGOFRUCTOSE-ENRICHED INULIN; PREBIOTIC; PROBIOTIC;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DIET; DIETARY FIBER; DISEASE MODELS, ANIMAL; FEMALE; INULIN; LACTOBACILLUS PLANTARUM; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBIOTICS; RATS; T-LYMPHOCYTE SUBSETS;

EID: 84908691382     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Siezen RJ and van Hylckama Vlieg JET: Genomic diversity and versatility of Lactobacillus plantarum, a natural metabolic engineer. Microb Cell Fact 10 (Suppl 1): 53-65, 2011.
2. Hirayama K and Rafter J: The role of probiotic bacteria in cancer prevention. Microbes Infect 2: 681-686, 2000.
3. Liong MT: Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in vivo evidence. Int J Mol Sci 9: 854-863, 2008.
4. Kim JE, Kim JY, Lee KW and Lee HJ: Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol 17: 1227-1235, 2007.
5. Biffi A, Coradini D, Larsen R, Riva L and Di Fronzo G: Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 28: 93-99, 1997.
6. Chen C, Hing MC and Kubow S: Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells. J Med Food 10: 416-422, 2007.
7. Liu CF and Pan TM: In vitro effects of lactic acid bacteria on cancer cell viability and antioxidant activity. J Food Drug Anal 18: 77-86, 2010.
8. van't Veer P, Dekker JM, Lamers JWJ, Kok FJ, Schouten EG, Brants HAM, Sturmans F and Hermus RJJ: Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res 49: 4020-4023, 1989.
9. van't Veer P, van Leer EM, Rietdijk A, Kok FJ, Schouten EG, Hermus RJ and Sturmans F: Combination of dietary factors in relation to breast cancer occurence. Int J Cancer 12: 649-653, 1991.
10. Rachid M, Matar C, Duarte J and Perdigón G: Effect of milk fermented with a Lactobacillus helveticus R389(+) proteolytic strain on the immune system and on the growth of 4T1 breast cancer cells in mice. Immunol Med Microbiol 47: 242-253, 2006.
11. de Moreno de LeBlanc A, Matar C, Farnworth E and Perdigón G: Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model. J Dairy Sci 90: 1920-1928, 2007.
12. Yazdi MH, Dallal MMS, Hassan ZM, Holakuyee M, Amiri SA, Abolhassani M and Mahdavi M: Oral administration of Lactobacillus acidophilus induces IL12 production in spleen cell culture of BALB/c mice bearing transplanted breast tumour. Br J Nutr 104: 227-232, 2010.
13. de Moreno de LeBlanc A, Matar C, LeBlanc N and Perdigón G: Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res 7: R477-R486, 2005.
14. Perdigón G, Vintini E, Alvarez S, Medina M and Medici M: Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 82: 1108-1114, 1999.
15. Perdigón G, Fuller R and Raya R: Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2: 27-42, 2001.
16. Ng SC, Hart AL, Kamm MA, Stagg AJ and Knight SC: Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15: 300-310, 2009.
17. Vissers YM, Snel J, Zuurendonk PF, Smit BA, Wichers HJ and Savelkoul HFJ: Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 59: 60-70, 2010.
18. Gill H and Prasad J: Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 606: 423-454, 2008.
19. Gibson GR and Roberfroid MB: Dietary modulation of the colonic microbiota: introducing the concept of prebiotics. J Nutr 125: 1401-1412, 1995.
20. Gibson GR and Delzenne N: Inulin and oligofructose: new scientific developments. Nutr Today 43: 54-59, 2008.
21. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M and Caderni G: Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23: 1953-1960, 2002.
22. Taper HS, Delzenne NM and Roberfroid MB. Growth inhibition of transplantable mouse tumors by non-digestible carbohydrates. Int J Cancer 71: 1109-1112, 1997.
23. Taper HS and Roberfroid M: Influence of inulin and oligofructose on breast cancer and tumor growth. J Nutr 129: 1488S-1491S, 1999.
24. Watzl B, Girrbach S and Roller M: Inulin, oligofructose and immunomodulation. Br J Nutr 93: S49-S55, 2005.
25. Russo J and Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5: 187-200, 2000.
26. Strojný L, Bomba A, Hijová E, Chmelárová A, Mojžišová G, Bertková I, Koprovičová J, Pomfy M, Strompfová V and Molokáčová M: Effects of a probiotic in combination with prebiotics on intestinal lactobacilli and coliforms and activities of bacterial enzymes in 1,2-dimethylhydrazine-exposed rats. Czech J Anim Sci 56 : 99-106, 2011.
27. Mehta RG: Experimental basis for the prevention of breast cancer. Eur J Cancer 36: 1275-1282, 2000.
28. Rice LJ, Chai YJ, Conti CJ, Willis RA and Locniskan MF: The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis. Nutr Cancer 24: 99-109, 1995.
29. Reddy BS and Rivenson A: Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-/] quinoline, a food mutagen. Cancer Res 53: 3914-3918, 1993.
30. Hadrup S, Donia M and Straten P: Effector CD4 and CD8 T-cells and their role in the tumor microenvironment. Cancer Microenviron 6: 123-133, 2013.
31. + follicular helper T-cell infiltration predicts breast cancer survival. J Clin Invest 123: 2873-2892, 2013.
32. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG and Woo HJ: Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 5: 41-48, 2004.
33. + T-cell effector function in situ. Blood 98: 2143-2151, 2001.
34. Calzascia T, Pellegrini M, Hall H, Sabbagh L, Ono N, Elford AL, Mak TV and Ohashi PS: TNFα is critical for antitumor but not antiviral T-cell immunity in mice. J Clin Invest 117: 3833-3845, 2007.
35. Vegh I and de Salamanca RE: Prolactin, TNFα and nitric oxide expression in N-nitroso-N-methylurea-induced-mammary tumours. J Carcinog 6: 18-25, 2007.
36. Fahmi T, Esendagli G, Yilmaz G, Kansu E and Guc D: Immune compartmentalization of T-cell subsets in chemically-induced breast cancer. Scand J Immunol 72: 339-348, 2010.
37. Ben-Baruch A: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5: 31-36, 2003.